CAS 125314-13-8

Formula: C19H15N3O2

InChI: InChI=1S/C19H15N3O2/c1-22-10-14(13-7-2-3-8-15(13)22)17-16(18(23)21-19(17)24)11-5-4-6-12(20)9-11/h2-10H,20H2,1H3,(H,21,23,24)

InChI key: RGTAEYDIDMGJLX-UHFFFAOYSA-N

SMILES: CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CC(=CC=C4)N

CP21R7

CAS: 125314-13-8

Formula: C₁₉H₁₅N₃O₂

Purity: 99%

Color and Shape: Solid

Molecular weight: 317.3413

Ref: IN-DA000NHH

CP21R7

CAS: 125314-13-8

CP21R7

Formula: C₁₉H₁₅N₃O₂

Purity: ≥95%

Molecular weight: 317.34

Ref: 54-BUP02838

CP21R7

CAS: 125314-13-8

CP21 is a specific GSK3β inhibitor, used to activate stem cells for differentiation, often paired with BMP4 for mesodermal fate.

Formula: C₁₉H₁₅N₃O₂

Purity: 96.14% - 99.16%

Color and Shape: Solid

Molecular weight: 317.34

Ref: TM-T3684

CP21R7

CAS: 125314-13-8

3-(3-Aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione

Formula: C₁₉H₁₅N₃O₂

Purity: 99%

Molecular weight: 317.34

Ref: IN-DG630056

CP21R7

CAS: 125314-13-8

Purity: 99%

Molecular weight: 317.116

Ref: 10-F861658

CP 21

CAS: 125314-13-8

CP 21 is a drug that has been found to be effective in the treatment of autoimmune diseases and cancer, with a high specificity for cancer tissues. CP 21 is a humanized antibody fragment that binds to β-catenin protein, which is involved in the activation of Wnt signaling pathways. CP 21 has been shown to inhibit the proliferation of chronic kidney cells and can reduce the glomerular filtration rate in rats. CP 21 also blocks the binding of β-catenin to other proteins, inhibiting its activity. This drug may also have therapeutic potential in treating neoplastic diseases such as colon cancer and breast cancer.

Formula: C₁₉H₁₅N₃O₂

Purity: Min. 95%

Molecular weight: 317.11643

Ref: 3D-FA145499